US Pharma MarketingThe post Nyxoah implants first patient in BREATHE study of Genio appeared first on Medical Device Network.
Nyxoah implants first patient in BREATHE study of Genio
Belgium medical technology firm Nyxoah has implanted the first patient in BREATHE, its US post-approval study of the Genio system for OSA. Nyxoah plans to implant up to 229 patients at 25 US clinical sites, with follow-up lasting five years. The trial participants are adults with moderate to severe OSA. Credit: daniiD / Shutterstock.com. Belgium-based medical technology company Nyxoah has implanted the first patient in BREATHE, its US post-approval study of the Genio system for obstructive sleep apnoea (OSA). The procedure was carried out by South Florida ENT Associates otolaryngologist Rolando Molina. Combine business intelligence and editorial excellence to reach…
Belgium medical technology firm Nyxoah has implanted the first patient in BREATHE, its US post-approval study of the Genio system for OSA.
Source: Medical Device Network